शेयर मूल्य

तारीख	Hangzhou Tigermed Consulting Co शेयर मूल्य
11/9/2025	61.22 undefined
10/9/2025	64.35 undefined
9/9/2025	64.67 undefined
8/9/2025	67.06 undefined
5/9/2025	66.47 undefined
4/9/2025	62.50 undefined
3/9/2025	66.19 undefined
2/9/2025	66.08 undefined
1/9/2025	65.09 undefined
29/8/2025	63.51 undefined
28/8/2025	63.74 undefined
27/8/2025	64.01 undefined
26/8/2025	65.40 undefined
25/8/2025	68.65 undefined
22/8/2025	66.45 undefined
21/8/2025	66.66 undefined
20/8/2025	66.28 undefined
19/8/2025	67.02 undefined
18/8/2025	68.22 undefined
15/8/2025	69.66 undefined
14/8/2025	68.97 undefined

तारीख	Hangzhou Tigermed Consulting Co राजस्व	Hangzhou Tigermed Consulting Co EBIT	Hangzhou Tigermed Consulting Co लाभ
2030e	14.57 अरब undefined	0 undefined	0 undefined
2029e	12.87 अरब undefined	5.55 अरब undefined	0 undefined
2028e	11.23 अरब undefined	4.94 अरब undefined	0 undefined
2027e	9.15 अरब undefined	1.91 अरब undefined	1.77 अरब undefined
2026e	8.06 अरब undefined	1.55 अरब undefined	1.43 अरब undefined
2025e	7.23 अरब undefined	1.27 अरब undefined	1.21 अरब undefined
2024	6.6 अरब undefined	1.09 अरब undefined	405.14 मिलियन undefined
2023	7.38 अरब undefined	1.71 अरब undefined	2.02 अरब undefined
2022	7.09 अरब undefined	1.78 अरब undefined	2.01 अरब undefined
2021	5.21 अरब undefined	1.43 अरब undefined	2.87 अरब undefined
2020	3.19 अरब undefined	956.7 मिलियन undefined	1.75 अरब undefined
2019	2.8 अरब undefined	802.8 मिलियन undefined	841.6 मिलियन undefined
2018	2.3 अरब undefined	628 मिलियन undefined	472.2 मिलियन undefined
2017	1.69 अरब undefined	423.6 मिलियन undefined	301 मिलियन undefined
2016	1.17 अरब undefined	167.5 मिलियन undefined	140.7 मिलियन undefined
2015	957 मिलियन undefined	210.9 मिलियन undefined	156.3 मिलियन undefined
2014	624.6 मिलियन undefined	153.8 मिलियन undefined	125.5 मिलियन undefined
2013	336.5 मिलियन undefined	89 मिलियन undefined	94.1 मिलियन undefined
2012	254.3 मिलियन undefined	66.7 मिलियन undefined	67.7 मिलियन undefined
2011	193.3 मिलियन undefined	54 मिलियन undefined	47.8 मिलियन undefined
2010	122.8 मिलियन undefined	34.5 मिलियन undefined	31.7 मिलियन undefined
2009	62.8 मिलियन undefined	7.1 मिलियन undefined	7.8 मिलियन undefined

2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2021	2022	2023	2024

0.02	0.04	0.09	0.56	0.53	0.45	0.24	0.54	0.61	0.7	2.11	9.99	8.57	8.41	7.81	7.48	2.14
0.02	0.02	0.05	0.09	0.13	0.3	0.38	0.45	0.63	0.78	1.16	1.32	2.1	2.09	3.03	3.63	3.86
1	2	5	8	10	10	42	72	67	58	64	119	75.85	82.78	98.29	109.23	131.19
0	0	0	0	0	0	0	0	0	1	1	5	6.1	6.1	22.2	23.4	31.96
1	21	8	4	8	21	23	36	34	64	41	220	94.79	260.73	153.97	103.3	134.07
0.04	0.09	0.14	0.66	0.68	0.79	0.69	1.09	1.35	1.6	3.37	11.65	10.85	10.85	11.11	11.34	6.3
0.02	0.02	0.02	0.05	0.08	0.15	0.19	0.2	0.2	0.26	0.43	0.68	1.12	1.14	1.34	1.49	1.7
0	0	0	0	0.02	0.05	0.19	0.46	0.88	1.33	2.36	5.37	9.5	9.5	11.8	13.22	16.77
0	0	0	0	0	0	0	0	0	0	0	0	75.85	0	0	0	0
0	0	8	9	10	19	14	13	17	28	96	142	250.64	250.64	338.12	371.13	336.88
0.01	0.01	0.01	0.01	0.02	0.34	0.47	0.6	1.05	1.03	1.16	1.45	1.78	1.78	2.49	2.76	3.23
0	1	3	2	2	15	50	17	87	36	122	223	219	219	380.99	492.47	341.58
0.03	0.03	0.04	0.07	0.13	0.57	0.92	1.29	2.24	2.68	4.16	7.86	12.95	12.89	16.34	18.34	22.37
0.07	0.12	0.19	0.73	0.81	1.36	1.61	2.39	3.58	4.28	7.53	19.51	23.8	23.74	27.45	29.68	28.67

30	40	40	53	107	215	433	475	500	500	750	872	872.44	872.44	872.42	872.42	864.95
0.01	0.03	0.03	0.49	0.44	0.38	0.18	0.67	1.27	1.32	1.71	12	11.89	11.89	11.85	11.71	10.77
0	0.03	0.08	0.14	0.19	0.28	0.39	0.48	0.72	1.1	1.94	3.48	6.09	6.09	7.66	9.21	9.13
0	0	0	0	0	-0.01	-0	0	-0	-0	0.03	-0.09	2.33	-0.16	0.06	0.09	0.09
0	0	0	0	0	0	0	0	0	0	0	0	0	0	8.88	8.83	6.09
0.04	0.09	0.14	0.69	0.74	0.86	1	1.63	2.49	2.92	4.42	16.25	21.17	18.69	20.45	21.9	20.86
0	0	2	12	14	17	10	15	24	44	75	101	147.87	125.75	157.96	249.31	257.29
0	1	3	6	8	22	27	43	55	89	156	183	350.68	350.68	403.5	461.53	355.48
0.02	0.02	0.03	0.02	0.03	0.08	0.18	0.2	0.32	0.41	0.63	0.78	1.35	1.33	1.15	0.91	0.9
0	0	0	0	0	0.27	0.26	0.18	0.27	0.64	0.89	0.02	0.49	0.53	1.88	1.99	1.95
0	0	0	0	0	0	0	0	63	29	33	52	74.52	74.52	137.32	519.57	201.58
0.02	0.02	0.04	0.04	0.05	0.39	0.47	0.44	0.73	1.21	1.79	1.14	2.41	2.41	3.73	4.14	3.66
0	0	0	0	0	7	24	33	32	19	154	279	406.84	406.84	733.62	857.33	722.97
0	0	0	0	0	4	9	17	13	14	46	132	201.54	201.54	214.39	213.98	201.8
0	1	3	0	0	43	40	64	4	4	20	97	-3,351.33	114.88	87.9	17.13	19.92
0	0	0	0	0	0.05	0.07	0.11	0.05	0.04	0.22	0.51	-2.74	0.72	1.04	1.09	0.94
0.02	0.02	0.04	0.04	0.05	0.44	0.54	0.55	0.78	1.25	2.01	1.65	-0.33	3.14	4.77	5.23	4.61
0.07	0.12	0.18	0.73	0.8	1.3	1.55	2.18	3.27	4.16	6.43	17.9	20.84	21.83	25.22	27.12	25.47

2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2021	2022
0	0	0	0	0	0	0	0	0	0	0	0	2.87	0	0
0	0	0	0	0	0	0	0	0	0	0	0	188	0	329
0	0	0	0	0	0	0	0	0	0	0	0	0	0	-7
3	-10	-16	-93	-104	-238	-462	-552	-671	-921	-1,157	-1,314	-98	-1,734	-2,420
0	0	0	0	0	0	0	0	0	0	0	0	-1,548	0	-285
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-3	-4	-15	-17	-26	-41	-59	-71	-127	-140	-234	-241	-321	-321	-594
0.02	0.03	0.04	0.02	0.08	0.04	0.19	0.19	0.32	0.52	0.53	1	1.42	1.42	1.36
-13	-8	-16	-21	-37	-38	-87	-61	-46	-91	-102	-156	-368	-368	-448
-34	-20	4	-22	-139	-219	-413	-530	-846	-366	-638	-2,367	-2,782	-2,782	-2,789
-20	-12	20	-1	-102	-181	-326	-468	-800	-274	-535	-2,210	-2,414	-2,414	-2,340
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0.23	-0.01	-0.05	0.08	0.34	0.18	-0.9	0.4	0.49	1.61
0	0	0	0	0	0	0	0	0	0	0	0	-227	0	-87
0	0.02	0	0.48	-0.04	0.12	0.01	0.49	0.7	0.01	1.43	9.34	-0.16	-0.16	0.81
0	0.02	0	0.48	0	-0.06	0.07	0.59	0.69	-0.2	1.52	10.51	-0.05	-0.37	-0.31
0	0	0	0	-43	-46	-46	-59	-62	-126	-266	-271	-284	-284	-491
0.01	0.07	0.11	0.6	0.1	0.27	0.51	0.98	1.28	1.76	3.26	10.48	1.95	1.9	3.78
8	18.3	22.5	-6.7	39.7	5.6	98.6	130.2	269	430.5	424.7	842.2	1,055.18	1,055.18	908.9
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Hangzhou Tigermed Consulting Co सकल मार्जिन	Hangzhou Tigermed Consulting Co लाभ मार्जिन	Hangzhou Tigermed Consulting Co EBIT मार्जिन	Hangzhou Tigermed Consulting Co लाभ मार्जिन
2030e	33.99 %	0 %	0 %
2029e	33.99 %	43.09 %	0 %
2028e	33.99 %	43.96 %	0 %
2027e	33.99 %	20.87 %	19.29 %
2026e	33.99 %	19.19 %	17.75 %
2025e	33.99 %	17.49 %	16.74 %
2024	33.99 %	16.5 %	6.14 %
2023	38.53 %	23.2 %	27.42 %
2022	39.64 %	25.12 %	28.32 %
2021	43.55 %	27.42 %	55.13 %
2020	47.43 %	29.97 %	54.81 %
2019	46.48 %	28.64 %	30.02 %
2018	43.1 %	27.3 %	20.52 %
2017	42.94 %	25.11 %	17.84 %
2016	38.03 %	14.26 %	11.98 %
2015	44.12 %	22.04 %	16.33 %
2014	47.33 %	24.62 %	20.09 %
2013	45.05 %	26.45 %	27.96 %
2012	46.24 %	26.23 %	26.62 %
2011	45.11 %	27.94 %	24.73 %
2010	45.6 %	28.09 %	25.81 %
2009	34.39 %	11.31 %	12.42 %

तारीख	Hangzhou Tigermed Consulting Co प्रति शेयर बिक्री	Hangzhou Tigermed Consulting Co EBIT प्रति शेयर	Hangzhou Tigermed Consulting Co प्रति शेयर लाभ
2030e	16.88 undefined	0 undefined	0 undefined
2029e	14.91 undefined	0 undefined	0 undefined
2028e	13.02 undefined	0 undefined	0 undefined
2027e	10.6 undefined	0 undefined	2.05 undefined
2026e	9.34 undefined	0 undefined	1.66 undefined
2025e	8.38 undefined	0 undefined	1.4 undefined
2024	7.65 undefined	1.26 undefined	0.47 undefined
2023	8.53 undefined	1.98 undefined	2.34 undefined
2022	8.19 undefined	2.06 undefined	2.32 undefined
2021	5.99 undefined	1.64 undefined	3.3 undefined
2020	4 undefined	1.2 undefined	2.19 undefined
2019	3.76 undefined	1.08 undefined	1.13 undefined
2018	3.07 undefined	0.84 undefined	0.63 undefined
2017	2.25 undefined	0.56 undefined	0.4 undefined
2016	1.67 undefined	0.24 undefined	0.2 undefined
2015	1.47 undefined	0.32 undefined	0.24 undefined
2014	0.98 undefined	0.24 undefined	0.2 undefined
2013	0.53 undefined	0.14 undefined	0.15 undefined
2012	0.48 undefined	0.13 undefined	0.13 undefined
2011	0.4 undefined	0.11 undefined	0.1 undefined
2010	0.26 undefined	0.07 undefined	0.07 undefined
2009	0.15 undefined	0.02 undefined	0.02 undefined

तारीख	Hangzhou Tigermed Consulting Co लाभांश
2027e	0.32 undefined
2026e	0.26 undefined
2019e	0.23 undefined
2018e	0.13 undefined
2017e	0.07 undefined
2016e	0.07 undefined
2015e	0.07 undefined
2014e	0.07 undefined
2013e	0.07 undefined
2025	0.3 undefined
2024	0.57 undefined
2023	0.55 undefined
2022	0.5 undefined
2021	0.3 undefined
2020	0.28 undefined
2019e	0.23 undefined
2018e	0.13 undefined
2017e	0.07 undefined
2016e	0.07 undefined
2015e	0.07 undefined
2014e	0.07 undefined
2013e	0.07 undefined

तारीख	Hangzhou Tigermed Consulting Co वितरण अनुपात
2030e	15.93 %
2029e	15.82 %
2028e	16.12 %
2027e	15.84 %
2026e	15.49 %
2025e	17.01 %
2024	15.03 %
2023	14.45 %
2022	21.55 %
2021	9.09 %
2020	12.69 %
2019	20.65 %
2018	21.16 %
2017	16.67 %
2016	33.35 %
2015	27.79 %
2014	33.35 %
2013	44.47 %
2012	14.45 %
2011	14.45 %
2010	14.45 %
2009	14.45 %

तिथि	EPS-अनुमान	वास्तविक EPS	रिपोर्टिंग तिमाही
30/6/2025	0.35	0.26 (-26.39 %)	2025 Q2
31/3/2025	0.27	0.19 (-29.03 %)	2025 Q1
31/12/2024	0.53	-0.47 (-189.32 %)	2024 Q4
30/9/2024	0.54	0.37 (-31.53 %)	2024 Q3
30/6/2024	0.5	0.3 (-40 %)	2024 Q2
31/3/2024	0.54	0.27 (-49.66 %)	2024 Q1
31/12/2023	0.46	0.17 (-63.33 %)	2023 Q4
30/9/2023	0.75	0.57 (-24.4 %)	2023 Q3
30/6/2023	0.66	0.95 (44.11 %)	2023 Q2
31/3/2023	0.62	0.66 (6.43 %)	2023 Q1
31/12/2022	0.63	0.46 (-26.46 %)	2022 Q4
30/9/2022	0.67	0.48 (-28.39 %)	2022 Q3
30/6/2022	0.65	0.78 (20.23 %)	2022 Q2
31/3/2022	0.63	0.6 (-5.05 %)	2022 Q1
31/12/2021	0.45	1.27 (181.28 %)	2021 Q4
30/9/2021	0.41	0.61 (48.94 %)	2021 Q3
30/6/2021	0.55	0.92 (68.68 %)	2021 Q2
31/3/2021	0.39	0.52 (32.01 %)	2021 Q1
31/12/2020	0.18	0.49 (166.89 %)	2020 Q4
30/9/2020	0.35	0.39 (11.62 %)	2020 Q3
30/6/2020	0.28	0.99 (257.45 %)	2020 Q2
31/3/2020	0.28	0.34 (21.02 %)	2020 Q1
31/12/2019	0.33	0.43 (27.78 %)	2019 Q4
30/9/2019	0.22	0.23 (6.48 %)	2019 Q3
30/6/2019	0.26	0.28 (5.5 %)	2019 Q2
31/3/2019	0.19	0.19 (-0.31 %)	2019 Q1
31/12/2018	0.18	0.21 (14.65 %)	2018 Q4
30/9/2018	0.16	0.13 (-19.47 %)	2018 Q3
30/6/2018	0.16	0.16 (3.81 %)	2018 Q2
31/3/2018	0.12	0.13 (5.47 %)	2018 Q1
31/12/2017	0.14	0.13 (-5.23 %)	2017 Q4

%	नाम	शेयर	परिवर्तन	तारीख
20.53664 %	Ye (Xiaoping)	17,72,39,541	0	31/3/2025
5.98602 %	Cao (Xiaochun)	5,16,61,774	0	31/3/2025
3.58652 %	Zhong Ou Asset Management Co., Ltd.	3,09,53,082	9,26,000	31/3/2025
2.68689 %	E Fund Management Co. Ltd.	2,31,88,984	-10,49,558	31/3/2025
1.97172 %	Hwabao WP Fund Management Co., Ltd.	1,70,16,750	1,46,500	31/3/2025
1.91716 %	GF Fund Management Co., Ltd.	1,65,45,888	3,14,359	31/12/2024
1.16012 %	Shi (Xiao Li)	1,00,12,321	-10,700	31/3/2025
1.11808 %	AEGON-INDUSTRIAL Fund Management Co., Ltd.	96,49,465	-3,22,188	31/3/2025
0.95751 %	Harvest Fund Management Co., Ltd.	82,63,724	2,15,200	30/6/2025
0.94654 %	Yinhua Fund Management Co., Ltd.	81,69,050	33,50,750	31/12/2024
0.93796 %	Tianhong Asset Management Co., Ltd.	80,94,961	10,14,694	31/12/2024
0.88859 %	HuaAn Fund Management Co., Ltd.	76,68,850	21,51,001	31/12/2024
0.80767 %	China Asset Management Co., Ltd.	69,70,563	-12,24,730	31/12/2024
0.71750 %	China Universal Asset Management Co., Ltd.	61,92,319	16,57,577	31/12/2024
0.55255 %	China Southern Asset Management Co. Ltd.	47,68,690	7,73,588	31/12/2024
0.46185 %	Hermes Capital FIZ	39,85,976	-1,01,248	28/2/2025
0.37172 %	ICBC UBS Asset Management Co., Ltd.	32,08,100	19,21,001	31/12/2024
0.31401 %	Galaxy Asset Management Co., Ltd.	27,10,038	10,01,500	31/12/2024
0.24645 %	Bank of Communications Schroder Fund Management Co., Ltd.	21,26,937	-1,53,10,803	31/12/2024
0.24183 %	Guotai Asset Management Co., Ltd.	20,87,067	14,318	31/12/2024
0.20271 %	SWS MU Fund Management Co., Ltd.	17,49,491	16,74,200	31/12/2024
0.20093 %	Fullgoal Fund Management Co., Ltd.	17,34,076	-18,78,174	31/12/2024
0.20052 %	The Vanguard Group, Inc.	17,30,536	0	31/7/2025
0.17112 %	Morgan Stanley Investment Management (China) Company Limited.	14,76,800	7,78,300	31/12/2024
0.15892 %	GLG Partners LP	13,71,570	13,71,570	30/6/2025
0.15682 %	abrdn Asia Limited	13,53,394	0	30/6/2025
0.15354 %	Norges Bank Investment Management (NBIM)	13,25,114	1,72,012	31/12/2024
0.13637 %	UBS Asset Management (Hong Kong) Limited	11,76,954	-1,69,200	30/4/2025
0.13494 %	INVESCO Great Wall Fund Management Co. Ltd.	11,64,583	2,61,439	31/12/2024
0.13475 %	Penghua Fund Management Co., Ltd.	11,62,946	5,81,900	31/12/2024
0.09699 %	Zhong Hai Fund Management Co., Ltd.	8,37,100	-8,72,719	31/12/2024
0.08850 %	Huashang Fund Management Co., Ltd.	7,63,800	1,00,600	31/12/2024
0.07925 %	Rongtong Fund Management Co., Ltd.	6,83,966	-3,01,200	31/12/2024
0.07676 %	BlackRock Institutional Trust Company, N.A.	6,62,512	3,000	31/7/2025
0.05997 %	CCB Principal Asset Management Co., Ltd.	5,17,575	1,25,467	31/12/2024
0.05533 %	Bosera Asset Management Co., Ltd.	4,77,510	-41,400	31/12/2024
0.05374 %	GLG LLC	4,63,767	4,63,767	30/6/2025
0.05275 %	Golden Eagle Asset Management Co., Ltd.	4,55,244	2,61,100	31/12/2024
0.05031 %	Amundi Asset Management, SAS	4,34,172	2,400	31/7/2025
0.04867 %	BlackRock Advisors (UK) Limited	4,20,021	-6,400	31/7/2025
0.04802 %	Harvest Global Investments Limited	4,14,429	0	31/7/2025
0.04531 %	ABC-CA Fund Management Co., Ltd.	3,91,020	3,35,520	31/12/2024
0.04428 %	Great Wall Fund Management Co., Ltd.	3,82,159	-1,58,276	31/12/2024
0.04371 %	China Asset Management (Hong Kong) Limited	3,77,256	-38,700	30/6/2025
0.03834 %	Changsheng Fund Management Co., Ltd.	3,30,870	9,645	31/12/2024
0.03809 %	PengYang Asset Management Co., Ltd	3,28,693	-22,600	31/12/2024
0.03564 %	State Street Global Advisors (US)	3,07,576	4,300	31/7/2025
0.03448 %	Wellington Management Company, LLP	2,97,579	-29,160	30/6/2025
0.03427 %	Topsperity Fund Management Co., Ltd.	2,95,800	-47,500	31/12/2024
0.03069 %	Bank of China Investment Management Co., Ltd.	2,64,900	1,95,200	31/12/2024
0.02874 %	Lion Fund Management Co., Ltd.	2,48,053	-1,99,300	31/12/2024
0.02761 %	AXA-SPDB Investment Managers Co., Ltd.	2,38,326	2,28,300	31/12/2024
0.02706 %	Fidelity Management & Research (Hong Kong) Limited	2,33,505	0	30/6/2025
0.02634 %	China Post & Capital Fund Management Co., Ltd.	2,27,300	1,56,300	31/12/2024
0.02465 %	CPIC Fund Management Co., Ltd.	2,12,698	11,400	31/12/2024
0.02452 %	Maxwealth Fund Management Co., Ltd.	2,11,633	59,401	31/12/2024
0.02298 %	BlackRock (Singapore) Limited	1,98,335	37,632	31/7/2025
0.02228 %	Western Leadbank Fund Management Co., Ltd.	1,92,259	53,600	31/12/2024
0.02113 %	Hermes Investment Management Ltd.	1,82,335	-98,288	31/3/2025
0.01996 %	Truvalue Asset Management Co., Ltd.	1,72,300	1,66,200	31/12/2024
0.01976 %	Tibet Eastmoney Fund Management Co., Ltd.	1,70,500	19,700	31/12/2024
0.01969 %	JT Asset Management Co., Ltd.	1,69,958	59,258	31/12/2024
0.01868 %	Minsheng Royal Fund Management Company Ltd.	1,61,200	-1,09,500	31/12/2024
0.01847 %	SEB Asset Management (Denmark)	1,59,373	10	30/6/2025
0.01828 %	Wanjia Asset Management Co., Ltd.	1,57,800	-1,61,500	31/12/2024
0.01815 %	BOC International (China) Ltd.	1,56,600	-5,100	31/12/2024
0.01762 %	Taikang Asset Management Co., Ltd.	1,52,107	4,100	31/12/2024
0.01688 %	UBS SDIC Fund Management Co., Ltd.	1,45,712	86,200	31/12/2024
0.01688 %	Huatai Securities (Shanghai) Asset Management Co., Ltd.	1,45,700	31,000	31/12/2024
0.01622 %	Nikko Asset Management Asia Limited	1,40,004	1,40,004	30/11/2024
0.01612 %	Ninety One North America, Inc.	1,39,156	0	30/4/2025
0.01530 %	Ninety One SA Pty Ltd.	1,32,056	1,32,056	31/10/2024
0.01448 %	Mellon Investments Corporation	1,24,967	0	31/7/2025
0.01443 %	Mirae Asset Global Investments Co., Ltd.	1,24,562	229	30/6/2025
0.01397 %	Everbright PGIM Fund Management Co., Ltd.	1,20,525	-1,04,400	31/12/2024
0.01356 %	New China Fund Management Co., Ltd.	1,17,000	1,04,800	31/12/2024
0.01253 %	Baillie Gifford Overseas Ltd.	1,08,100	-20,500	30/6/2025
0.01219 %	Industrial Securities Assets Management Ltd.	1,05,200	70,900	31/12/2024
0.01193 %	Ping An Fund Management Company Limited	1,03,000	-1,37,400	31/12/2024
0.01179 %	Geode Capital Management, L.L.C.	1,01,757	0	30/6/2025
0.01142 %	Baoying Fund Management Co., Ltd.	98,600	98,600	31/12/2024
0.01059 %	BOSC Asset Management Co., Ltd.	91,400	70,700	31/12/2024
0.00990 %	CITIC Prudential Fund Management Co., Ltd.	85,400	800	31/12/2024
0.00990 %	Xingyin Fund Management Co., Ltd.	85,400	12,100	31/12/2024
0.00985 %	Beixin Ruifeng Fund Management Co., Ltd.	85,000	10,000	31/12/2024
0.00975 %	Amundi Japan Ltd.	84,153	6,900	31/7/2025
0.00973 %	Green Fund Management Co., Ltd.	84,000	84,000	31/12/2024
0.00928 %	China Life AMP Asset Management Co., Ltd	80,109	37,200	31/12/2024
0.00826 %	BlackRock Investment Management (UK) Ltd.	71,300	37,000	30/4/2025
0.00754 %	Northern Trust Global Investments Limited	65,059	255	30/6/2025
0.00750 %	Charles Schwab Investment Management, Inc.	64,700	0	31/7/2025
0.00738 %	Founder Fubon Fund Management Co., Ltd.	63,700	3,500	31/12/2024
0.00728 %	Krane Funds Advisors, LLC	62,850	3,800	31/7/2025
0.00677 %	JPMorgan Asset Management (China) Company Limited.	58,427	-4,42,979	31/12/2024
0.00672 %	PGGM Vermogensbeheer B.V.	57,969	180	31/3/2025
0.00647 %	Samsung Asset Management Co., Ltd.	55,863	-105	30/6/2025
0.00630 %	State Street Global Advisors (UK) Ltd.	54,409	0	31/7/2025
0.00616 %	California State Teachers Retirement System	53,200	-2,20,531	30/6/2024
0.00596 %	CSOP Asset Management Limited	51,400	-4,700	30/6/2025
0.00541 %	Golden Trust Sinopac Fund Management Co., Ltd.	46,700	-6,72,300	31/12/2024

What values and corporate philosophy does Hangzhou Tigermed Consulting Co represent?

Hangzhou Tigermed Consulting Co Ltd represents values of trust, innovation, and excellence in the field of clinical research and drug development. As a leading contract research organization, Tigermed is committed to providing high-quality services and solutions to pharmaceutical companies globally. With a strong focus on integrity and professionalism, the company aims to assist clients in achieving their clinical development goals efficiently. Moreover, Tigermed values collaboration, aiming to foster meaningful partnerships with its clients and professionals in the healthcare industry. Through cutting-edge technology and a customer-centric approach, Hangzhou Tigermed Consulting Co Ltd strives to be a reliable and strategic partner in advancing healthcare outcomes.

In which countries and regions is Hangzhou Tigermed Consulting Co primarily present?

Hangzhou Tigermed Consulting Co Ltd is primarily present in China, as it is a Chinese company. However, it also has a significant presence in other countries and regions. With its global expansion strategy, Hangzhou Tigermed Consulting Co Ltd has established branches and offices in numerous locations worldwide. These include the United States, Japan, South Korea, Europe, Australia, and Southeast Asia. This widespread presence allows Hangzhou Tigermed Consulting Co Ltd to offer its comprehensive range of pharmaceutical and clinical research services to clients internationally.

What significant milestones has the company Hangzhou Tigermed Consulting Co achieved?

Hangzhou Tigermed Consulting Co Ltd has achieved significant milestones in its history. As a leading contract research organization (CRO), the company has successfully established a global presence and expanded its service offerings. It has demonstrated its expertise in clinical research, regulatory affairs, and data management, serving clients across various therapeutic areas. Tigermed Consulting has also formed strategic partnerships with renowned pharmaceutical companies, positioning itself as a trusted partner in drug development and clinical trials. With its commitment to innovation and quality, Hangzhou Tigermed Consulting Co Ltd continues to make substantial advancements in the field of healthcare and contribute to improved patient outcomes.

What is the history and background of the company Hangzhou Tigermed Consulting Co?

Hangzhou Tigermed Consulting Co Ltd is a leading contract research organization (CRO) based in China. Founded in 2004, the company has rapidly grown to become one of the largest independent CROs in the country. Tigermed specializes in providing comprehensive clinical research and development services to pharmaceutical and biotech companies globally. With a strong focus on clinical trial management, regulatory affairs, and data management, Tigermed has established a solid reputation for delivering high-quality solutions to its clients. The company's commitment to excellence and extensive experience in the industry has enabled it to forge strong partnerships and contribute significantly to the advancement of healthcare research.

Who are the main competitors of Hangzhou Tigermed Consulting Co in the market?

Some of the main competitors of Hangzhou Tigermed Consulting Co Ltd in the market include PPD Inc., ICON plc, QuintilesIMS, PAREXEL International Corporation, and Wuxi AppTec.

In which industries is Hangzhou Tigermed Consulting Co primarily active?

Hangzhou Tigermed Consulting Co Ltd is primarily active in the pharmaceutical and biotech industries.

What is the business model of Hangzhou Tigermed Consulting Co?

The business model of Hangzhou Tigermed Consulting Co Ltd revolves around providing comprehensive and integrated clinical research services to support the development and marketing of pharmaceutical, biotechnological, and medical device products. As a leading Contract Research Organization (CRO) in China, Tigermed offers a wide range of services including project planning, clinical trial management, regulatory affairs, data management, statistical analysis, and quality assurance. By leveraging their expertise, experience, and strategic partnerships, Hangzhou Tigermed Consulting Co Ltd caters to the growing needs of domestic and international clients in the healthcare industry.

Hangzhou Tigermed Consulting Co 2025 की कौन सी KGV है?

Hangzhou Tigermed Consulting Co का केजीवी 43.65 है।

Hangzhou Tigermed Consulting Co 2025 की केयूवी क्या है?

Hangzhou Tigermed Consulting Co KUV 7.31 है।

Hangzhou Tigermed Consulting Co का AlleAktien गुणवत्ता स्कोर क्या है?

Hangzhou Tigermed Consulting Co के लिए AlleAktien गुणवत्ता स्कोर 7/10 है।

Hangzhou Tigermed Consulting Co 2025 का वार्षिक कारोबार कितना है?

अपेक्षित Hangzhou Tigermed Consulting Co का व्यापार वोल्यूम 7.23 अरब CNY है।

Hangzhou Tigermed Consulting Co 2025 का लाभ कितना है?

अपेक्षित Hangzhou Tigermed Consulting Co लाभ 1.21 अरब CNY है।

Hangzhou Tigermed Consulting Co क्या करता है?

The Hangzhou Tigermed Consulting Co Ltd is a leading company in the field of clinical research, offering a wide range of services to its customers. The company was founded in 2004 and has its headquarters in Hangzhou, China. With offices in various cities in China, Europe, and the USA, the company now has over 800 employees worldwide. The business model of Tigermed Consulting is to support companies in developing and bringing new products to market. To this end, the company offers a wide range of services that span the entire product lifecycle. The company provides customers with support in the planning, execution, and evaluation of clinical studies, following applicable regulations and guidelines. The company specializes in clinical studies, regulatory affairs, medical devices, biostatistics, and medical writing services. Tigermed Consulting offers unique services to its customers, providing comprehensive solutions for their clinical studies, regulatory matters, and medical products. The company has experienced significant growth in recent years by offering a broad range of customizable services tailored to the specific needs of its customers. Overall, the business model of Tigermed Consulting aims to help its customers stay competitive and successfully bring their products to market. In a world driven by new technologies and innovations, it is important to leverage the expertise of companies like Tigermed Consulting to operate a successful and profitable business.

Hangzhou Tigermed Consulting Co डिविडेंड कितना है?

Hangzhou Tigermed Consulting Co एक वर्ष में बार वितरण करते हुए 0.5 CNY का डिविडेंड देता है।

Hangzhou Tigermed Consulting Co कितनी बार लाभांश देती है?

वर्तमान में Hangzhou Tigermed Consulting Co के लिए डिविडेंड की गणना नहीं की जा सकती है या फिर कंपनी डिविडेंड नहीं दे रही है।

Hangzhou Tigermed Consulting Co ISIN क्या है?

Hangzhou Tigermed Consulting Co का ISIN CNE100001KV8 है।

Hangzhou Tigermed Consulting Co टिकर क्या है?

Hangzhou Tigermed Consulting Co का टिकर 300347.SZ है।

Hangzhou Tigermed Consulting Co कितना लाभांश देती है?

पिछले 12 महीनों में Hangzhou Tigermed Consulting Co ने 0.57 CNY का डिविडेंड भुगतान किया। यह लगभग 0.93 % के डिविडेंड यील्ड के बराबर है। आगामी 12 महीनों के लिए Hangzhou Tigermed Consulting Co अनुमानतः 0.26 CNY का डिविडेंड भुगतान करेगी।

Hangzhou Tigermed Consulting Co का डिविडेंड यील्ड कितना है?

Hangzhou Tigermed Consulting Co का वर्तमान डिविडेंड यील्ड 0.93 % है।

Hangzhou Tigermed Consulting Co कब लाभांश देगी?

Hangzhou Tigermed Consulting Co तिमाही आधार पर लाभांश का भुगतान करता है। यह जून, अगस्त, अगस्त, जुलाई महीनों में वितरित किया जाता है।

Hangzhou Tigermed Consulting Co का लाभांश कितना सुरक्षित है?

Hangzhou Tigermed Consulting Co ने पिछले 0 वर्षों में हर साल डिविडेंड का भुगतान किया।

Hangzhou Tigermed Consulting Co का लाभांश कितना है?

आने वाले 12 महीनों के लिए 0.26 CNY के डिविडेंड की उम्मीद की जा रही है। यह 0.42 % के डिविडेंड यील्ड के बराबर है।

Hangzhou Tigermed Consulting Co किस सेक्टर में है?

Hangzhou Tigermed Consulting Co को 'स्वास्थ्य' क्षेत्र से संबद्ध किया गया है।

Wann musste ich die Aktien von Hangzhou Tigermed Consulting Co kaufen, um die vorherige Dividende zu erhalten?

Hangzhou Tigermed Consulting Co का आखिरी लाभांश प्राप्त करने के लिए, जो 17/6/2025 को 0.3 CNY की राशि में था, आपको Ex-दिन 17/6/2025 से पहले इसे अपनी डिपो में रखना आवश्यक था।

Hangzhou Tigermed Consulting Co ने आखिरी बार लाभांश कब भुगतान किया था?

अंतिम लाभांश का भुगतान 17/6/2025 को किया गया था।

Hangzhou Tigermed Consulting Co का लाभांश 2024 में कितना था?

2024 में Hangzhou Tigermed Consulting Co द्वारा 0.55 CNY डिविडेंड के रूप में वितरित किए गए थे।

Hangzhou Tigermed Consulting Co डिविडेंड किस मुद्रा में वितरित करता है?

Hangzhou Tigermed Consulting Co के दिविडेंड CNY में वितरित किए जाते हैं।

2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025e	2026e	2027e	2028e	2029e	2030e
0.06	0.12	0.19	0.25	0.34	0.62	0.96	1.17	1.69	2.3	2.8	3.19	5.21	7.09	7.38	6.6	7.23	8.06	9.15	11.23	12.87	14.57
-	96.77	58.20	31.61	32.28	85.71	53.37	22.68	43.70	36.34	21.87	13.88	63.31	35.91	4.22	-10.58	9.53	11.49	13.51	22.75	14.56	13.19
33.87	45.90	45.08	46.06	44.94	47.28	44.10	37.99	42.92	43.09	46.45	47.43	43.54	39.63	38.53	33.98	31.03	27.83	24.52	19.98	17.44	15.40
0.02	0.06	0.09	0.12	0.15	0.3	0.42	0.45	0.72	0.99	1.3	1.51	2.27	2.81	2.85	2.24	0	0	0	0	0	0
0.01	0.03	0.05	0.07	0.09	0.13	0.16	0.14	0.3	0.47	0.84	1.75	2.87	2.01	2.02	0.41	1.21	1.43	1.77	0	0	0
-	342.86	51.61	42.55	40.30	32.98	24.80	-10.26	115.00	56.81	78.18	107.97	64.32	-30.20	0.90	-79.99	198.77	18.18	23.43	-	-	-
-	-	-	-	0.13	0.13	0.13	0.13	0.13	0.27	0.47	0.28	0.30	0.50	0.55	0.57	0.30	0.26	0.32	-	-	-
0	0	0	0	0	0	0	0	0	107.69	74.07	-40.43	7.14	66.67	10	3.64	-47.37	-13.33	23.08	0	0	0
405.2	473	480	533.6	640.8	638.1	650	703.3	750.3	750.3	744.8	799	870.96	864.89	865.32	863.04	0	0	0	0	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

प्रत्यक्ष निर्गम	118.73
खरीदी गई ऊर्जा से संबंधित अप्रत्यक्ष उत्सर्जन	13,731.49
वर्तमान श्रृंखला में परोक्ष उत्सर्जन
CO₂ उत्सर्जन	13,850.21
CO₂-कमी रणनीति
कोयला ऊर्जा
परमाणु ऊर्जा
प्रयोगशाला में जानवरों पर परीक्षण
पेल्ज़ और लेदर
कीटनाशक
ताड़ का तेल
तंबाकू
जेनेटिक इंजीनियरिंग
क्लाइमाकॉन्ज़ेप्ट
स्थायी वानिकी
पुनर्चक्रण नियमन
पर्यावरण के अनुकूल पैकेजिंग
खतरनाक पदार्थ
ईंधन खपत और दक्षता
जल उपयोग और दक्षता

महिला कर्मचारियों का प्रतिशत	82.565
प्रबंधन में महिलाओं की हिस्सेदारी
एशियाई कर्मचारियों की हिस्सेदारी
एशियाई प्रबंधन की हिस्सेदारी
हिस्पैनिक/लैटिनो कर्मचारियों का प्रतिशत
हिस्पैनो/लैटिनो प्रबंधन हिस्सा
श्वेत अधिकारियों का प्रतिशत
काले प्रबंधन की हिस्सेदारी
श्वेत कर्मचारियों का अनुपात
श्वेत प्रबंधन में हिस्सेदारी
वयस्क सामग्री
अल्कोहल
रक्षा
शस्त्र
जुआ
सैन्य अनुबंध
मानवाधिकार अवधारणा
गोपनीयता नीतи
काम और स्वास्थ्य सुरक्षा
कैथोलिक

स्थिरता रिपोर्ट
स्टेकहोल्डर-इंगेजमेंट
नीतियाँ वापस बुलाने की
प्रतिस्पर्धा कानून

Hangzhou Tigermed Consulting Co टिकर	Hangzhou Tigermed Consulting Co FIGI
300347:CH	BBG002PKXG01
300347:CS	BBG002QKZ361
300347:C2	BBG00F13DR59

किंवदंती निवेशक Eulerpool पर भरोसा करते हैं

Hangzhou Tigermed Consulting Co शेयर 300347.SZ

शेयर मूल्य

शेयर मूल्य

टिकर300347.SZ

ISINCNE100001KV8

Hangzhou Tigermed Consulting Co शेयर कीमत

कुर्स

अवलोकन

इंट्राडे सुविधा

कुल रिटर्न और सापेक्षिक मूल्य परिवर्तन

व्याख्या और निवेश

Hangzhou Tigermed Consulting Co शेयर मूल्य इतिहास

Hangzhou Tigermed Consulting Co शेयर बिक्री, EBIT, लाभ

उमसात्ज, गेविन्न & EBIT

उमसात्ज, EBIT और आय की समझ

सालाना विश्लेषण और तुलनाएँ

निवेश के लिए उम्मीदें उपयोग करें

निवेश संविधान

Hangzhou Tigermed Consulting Co बिक्री, लाभ और ईबीआईटी इतिहास

Hangzhou Tigermed Consulting Co शेयर मापदंड

गुआव

आय और विकास

सकल मार्जिन

EBIT और EBIT-मार्जिन

आय और विकास

शेयर बकाया

वार्षिक तुलना की व्याख्या

अपेक्षाएँ और अनुमान

बिलान्ज

बिलान्ज की समझ

संपत्तियाँ

दायित्व

मालिकाना हक

वर्ष-दर-वर्ष विश्लेषण

डेटा की व्याख्या

Hangzhou Tigermed Consulting Co शेयर मार्जिन

मार्जिन

ब्रूटोमार्जिन की समझ

EBIT मार्जिन विश्लेषण

उम्सात्झ्मार्जिन अंतर्दृष्टि

अपेक्षाओं की व्याख्या

तुलनात्मक विश्लेषण

Hangzhou Tigermed Consulting Co मार्जिन इतिहास

Hangzhou Tigermed Consulting Co शेयर बिक्री, EBIT, प्रति शेयर लाभ

उमसत्ज़, EBIT और प्रति शेयर लाभ

प्रति शेयर उमसत्ज़

प्रति शेयर EBIT

प्रति शेयर आय

अनुमानित मान

Hangzhou Tigermed Consulting Co बिक्री, लाभ और EBIT प्रति शेयर इतिहास

Hangzhou Tigermed Consulting Co शेयर और शेयर विश्लेषण

अपने जीवन के सबसे अच्छे निवेश करो

Hangzhou Tigermed Consulting Co Fair Value के अनुसार मूल्यांकन

Fair Value

Fair Value की समझ

आय-आधारित Fair Value

राजस्व-आधारित Fair Value

लाभांश-आधारित Fair Value

अपेक्षाएँ और अनुमान

तुलनात्मक विश्लेषण

Hangzhou Tigermed Consulting Co का मूल्यांकन ऐतिहासिक P/E अनुपात, EBIT और P/S अनुपात के अनुसार

अपने जीवन के सबसे अच्छे निवेश करो

Hangzhou Tigermed Consulting Co संख्या शेयर

उमसत्ज़, EBIT और प्रति शेयर लाभ

प्रति शेयर उमसत्ज़

प्रति शेयर EBIT

प्रति शेयर आय

अनुमानित मान

Hangzhou Tigermed Consulting Co एक्टियन्स्प्लिट्स

Hangzhou Tigermed Consulting Co शेयर लाभांश

डिविडेंड

डिविडेंड संबंधी समीक्षा

व्याख्या और प्रयोग

निवेश रणनीति

Hangzhou Tigermed Consulting Co डिविडेंड इतिहास

Hangzhou Tigermed Consulting Co शेयर वितरण अनुपात

वितरण अनुपात

वार्षिक वितरण अनुपात क्या है?

डेटा की व्याख्या कैसे करें

टिकर
300347.SZ

ISIN
CNE100001KV8